This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 5 EPO patents. Top assignees: Smart Brain S.r.o., Biotechnologicky Ustav Av Cr, V.v.i., Mitotax S.r.o.. Active years: 2018-2023.
Company Filing History:
4 out of 4 
2 out of 3 
2 out of 2 Years Active: 2018-2023
Title: Innovations and Contributions of Inventor Jan Stursa
Introduction
Jan Stursa, an accomplished inventor based in Prague, Czech Republic, has made significant contributions to the field of medicinal chemistry through his patents. With four patents to his name, he has focused his efforts on developing innovative methods for treating various health disorders.
Latest Patents
Among his latest patents is a groundbreaking method for the treatment of senescence-related disorders. This invention relates to compounds of general formula (I), specifically targeting diseases such as idiopathic pulmonary fibrosis, sarcopenia, diabetes, obesity, osteoarthritis, chronic inflammations, glaucoma, cataracts, radiation-induced oral mucosis, renal transplantation, and prostatic hyperplasia. Jan Stursa's other notable patent involves phospholipid derivatives and their applications as medicaments. This invention concerns 1-acyl-lysophosphatidyl derivatives, where R is a C4 to C30 aliphatic hydrocarbyl chain, demonstrating promising potential in treating cancers such as melanoma, hepatocarcinoma, and gastrointestinal tract carcinomas.
Career Highlights
Jan Stursa has worked with esteemed institutions such as Smart Brain s.r.o. and the Institute of Biotechnology of the Czech Academy of Sciences. His innovative research and dedication to developing effective medical treatments showcase his commitment to advancing healthcare solutions.
Collaborations
Throughout his career, Jan Stursa has collaborated with other prominent figures in the field, including Lukas Werner and Jiri Neuzil. These partnerships have undoubtedly enriched his work and contributed to the valuable insights provided by his inventions.
Conclusion
Jan Stursa is a remarkable inventor whose contributions to the field of medicinal chemistry illustrate the importance of innovation in healthcare. His latest patents demonstrate a commitment to addressing complex medical challenges through research and collaboration. As he continues to develop groundbreaking treatments, Jan Stursa's impact on the industry will likely be felt for years to come.